- 专利标题： MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
-
申请号： US18557406申请日： 2022-04-28
-
公开(公告)号： US20240219385A1公开(公告)日： 2024-07-04
- 发明人: Thomas F. BUMOL , Xiaojun LI , Peter SKENE , Gregory Lee SZETO , Aarthi TALLA , Troy TORGERSON , Mark-Phillip PEBWORTH , Suhas VASAIKAR , Juliana M. MCELRATH
- 申请人： ALLEN INSTITUTE , FRED HUTCHINSON CANCER CENTER
- 申请人地址： US WA Seattle
- 专利权人： ALLEN INSTITUTE,FRED HUTCHINSON CANCER CENTER
- 当前专利权人： ALLEN INSTITUTE,FRED HUTCHINSON CANCER CENTER
- 当前专利权人地址： US WA Seattle; US WA Seattle
- 国际申请： PCT/US22/26841 2022.04.28
- 进入国家日期： 2023-10-26
- 主分类号： G01N33/569
- IPC分类号： G01N33/569
摘要：
In various embodiments, provided are immune response signatures that can be used for the diagnosis, monitoring, and treatment of long-term diseases and inflammatory disorders caused by viral infections. In some embodiments, the viral infection is SARS-CoV-2 infection. In some embodiments, the long-term disease is post-acute sequelae of SARS-CoV-2 infection (PASC).
信息查询
IPC分类:
